Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Receivables - Other: 2009-2025

Historic Receivables - Other for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $7.0 million.

  • Lifecore Biomedical's Receivables - Other rose 71.52% to $7.0 million in Q2 2025 from the same period last year, while for May 2025 it was $7.0 million, marking a year-over-year increase of 71.52%. This contributed to the annual value of $7.0 million for FY2025, which is 71.52% up from last year.
  • Per Lifecore Biomedical's latest filing, its Receivables - Other stood at $7.0 million for FY2025, which was up 71.52% from $4.1 million recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Receivables - Other ranged from a high of $10.6 million in FY2021 and a low of $3.2 million during FY2023.
  • Moreover, its 3-year median value for Receivables - Other was $4.1 million (2024), whereas its average is $4.7 million.
  • Per our database at Business Quant, Lifecore Biomedical's Receivables - Other crashed by 69.25% in 2023 and then skyrocketed by 71.52% in 2025.
  • Lifecore Biomedical's Receivables - Other (Yearly) stood at $10.6 million in 2021, then declined by 1.89% to $10.4 million in 2022, then crashed by 69.25% to $3.2 million in 2023, then climbed by 27.24% to $4.1 million in 2024, then spiked by 71.52% to $7.0 million in 2025.